|
Volumn 86, Issue 5, 2001, Pages 1331-1333
|
Usefulness and limitations of animal models of venous thrombosis: On behalf of the Subcommittee on Animal, Cellular, and Molecular Models of Thrombosis and Haemostasis of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTITHROMBOCYTIC AGENT;
BLOOD CLOTTING FACTOR 11;
HEPARIN;
HIRUDIN;
LOW MOLECULAR WEIGHT HEPARIN;
PLASMINOGEN ACTIVATOR INHIBITOR 1;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
BIOLOGICAL MODEL;
BLOOD CLOTTING;
DOSE RESPONSE;
DRUG EFFICACY;
HEMOSTASIS;
IN VIVO STUDY;
MEDICAL SOCIETY;
MOLECULAR DYNAMICS;
NONHUMAN;
NOTE;
PATHOGENESIS;
PRIORITY JOURNAL;
STANDARDIZATION;
THROMBOGENESIS;
VEIN THROMBOSIS;
ANIMAL;
ARTICLE;
DISEASE MODEL;
MEDICAL RESEARCH;
METHODOLOGY;
PUBLICATION;
STANDARD;
ANIMAL;
BIOMEDICAL RESEARCH;
DISEASE MODELS, ANIMAL;
PUBLICATIONS;
RESEARCH DESIGN;
VENOUS THROMBOSIS;
|
EID: 0035167859
PISSN: 03406245
EISSN: None
Source Type: Journal
DOI: 10.1055/s-0037-1616069 Document Type: Note |
Times cited : (29)
|
References (0)
|